Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

The regional Stoxx 600 index is down 0.18%, with France's CAC 40 and Germany's DAX lower by 0.43% and 0.22%, respectively.

From Novo Nordisk to UnitedHealth, onetime chief executives are returning to guide their former organizations in times of ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created ...